BMS-794833

B2055-5 Biovision each 235.2 EUR

BMS-986020

B2290-25 Biovision each 757.2 EUR

BMS-986020

B2290-5 Biovision each 235.2 EUR

BMS-663068

B2299-25 Biovision each 907.2 EUR

BMS-663068

B2299-5 Biovision each 274.8 EUR

BMS-986142

B2420-1 Biovision each 235.2 EUR

BMS-986142

B2420-5 Biovision each 757.2 EUR

BMS-582949

B1704-1 Biovision each 222 EUR

BMS-582949

B1704-5 Biovision each 705.6 EUR

BMS-303141

B1079-10 ApexBio 10 mg 177.6 EUR
Description: BMS-303141 is a potent inhibitor of ATP-citrate lyase with IC50 value of 0.13 ?M [1]. ATP-citrate lyase (ACL) is a cytosolic enzyme that responsible for the production of cytosolic acetyl-CoA, a precursor required for de novo biosyntheses of cholesterol and fatty acids.

BMS-303141

B1079-25 ApexBio 25 mg 296.4 EUR
Description: BMS-303141 is a potent inhibitor of ATP-citrate lyase with IC50 value of 0.13 ?M [1]. ATP-citrate lyase (ACL) is a cytosolic enzyme that responsible for the production of cytosolic acetyl-CoA, a precursor required for de novo biosyntheses of cholesterol and fatty acids.

BMS-303141

B1079-5.1 ApexBio 10 mM (in 1mL DMSO) 160.8 EUR
Description: BMS-303141 is a potent inhibitor of ATP-citrate lyase with IC50 value of 0.13 ?M [1]. ATP-citrate lyase (ACL) is a cytosolic enzyme that responsible for the production of cytosolic acetyl-CoA, a precursor required for de novo biosyntheses of cholesterol and fatty acids.

BMS-303141

B1079-50 ApexBio 50 mg 477.6 EUR
Description: BMS-303141 is a potent inhibitor of ATP-citrate lyase with IC50 value of 0.13 ?M [1]. ATP-citrate lyase (ACL) is a cytosolic enzyme that responsible for the production of cytosolic acetyl-CoA, a precursor required for de novo biosyntheses of cholesterol and fatty acids.

BMS-794833

B1438-10 ApexBio 10 mg 303.6 EUR
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833

B1438-5 ApexBio 5 mg 196.8 EUR
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833

B1438-5.1 ApexBio 10 mM (in 1mL DMSO) 212.4 EUR
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833

B1438-50 ApexBio 50 mg 999.6 EUR
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833

B1438-S ApexBio Evaluation Sample 97.2 EUR
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-378806

B1533-10 ApexBio 10 mg 366 EUR
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-378806

B1533-100 ApexBio 100 mg 1423.2 EUR
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-378806

B1533-5 ApexBio 5 mg 226.8 EUR
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-378806

B1533-5.1 ApexBio 10 mM (in 1mL DMSO) 282 EUR
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-378806

B1533-50 ApexBio 50 mg 1005.6 EUR
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-626529

B1557-25 Biovision each 966 EUR

BMS-626529

B1557-5 Biovision each 288 EUR

BMS-708163

B1622-25 Biovision each 966 EUR

BMS-708163

B1622-5 Biovision each 288 EUR

BMS-817378

B5862-10 ApexBio 10 mg 373.2 EUR
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility.

BMS-817378

B5862-5 ApexBio 5 mg 226.8 EUR
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility.

BMS-817378

B5862-50 ApexBio 50 mg 999.6 EUR
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility.

BMS-599626

1614-1 Biovision each 255.6 EUR

BMS-599626

1614-5 Biovision each 738 EUR

BMS-777607

2455-25 Biovision each 679.2 EUR

BMS-777607

2455-5 Biovision each 222 EUR

BMS-911543

2630-1 Biovision each 170.4 EUR

BMS-911543

2630-5 Biovision each 496.8 EUR

BMS-754807

2631-1 Biovision each 157.2 EUR

BMS-754807

2631-5 Biovision each 444 EUR

BMS-790052

27054 BPS Bioscience 5 mg 275 EUR
Description: BMS-790052 is a highly selective and highly potent inhibitor of hepatitis C virus (HCV) NS5A. The mean EC50 values of BMS-790052 are 50 and 9 pM for HCV genotype 1a and 1b replicons, respectively. BMS-790052 is inactive towards a panel of 10 RNA and DNA viruses, with EC50 higher than 10 µM.

BMS-303141

2821-10 Biovision each 248.4 EUR

BMS-303141

2821-50 Biovision each 823.2 EUR

BMS-754807

A1185-100 ApexBio 100 mg 1034.4 EUR
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies.

BMS-754807

A1185-25 ApexBio 25 mg 408 EUR
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies.

BMS-754807

A1185-5 ApexBio 5 mg 150 EUR
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies.

BMS-754807

A1185-5.1 ApexBio 10 mM (in 1mL DMSO) 184.8 EUR
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies.

BMS-509744

A3250-10 ApexBio 10 mg 494.4 EUR
Description: BMS-509744 is a selective inhibitor of ITK with IC50 value of 15 nM [1].ITK (IL-2-inducible T cell kinase) is an enzyme and plays an important role in T cell receptor signaling.

BMS-509744

A3250-5 ApexBio 5 mg 340.8 EUR
Description: BMS-509744 is a selective inhibitor of ITK with IC50 value of 15 nM [1].ITK (IL-2-inducible T cell kinase) is an enzyme and plays an important role in T cell receptor signaling.

BMS-509744

A3250-50 ApexBio 50 mg 2013.6 EUR
Description: BMS-509744 is a selective inhibitor of ITK with IC50 value of 15 nM [1].ITK (IL-2-inducible T cell kinase) is an enzyme and plays an important role in T cell receptor signaling.

BMS-626529

A3253-10 ApexBio 10 mg 408 EUR
Description: EC50HIV-1 attachment inhibitors represent a new class of entry inhibitors that prevent the initial interaction between virus and host cell by binding to the viral envelope protein gp120 and blocking attachment of the virus to the CD4 receptor on CD4+ T-cells.

BMS-626529

A3253-200 ApexBio 200 mg 2148 EUR
Description: EC50HIV-1 attachment inhibitors represent a new class of entry inhibitors that prevent the initial interaction between virus and host cell by binding to the viral envelope protein gp120 and blocking attachment of the virus to the CD4 receptor on CD4+ T-cells.

BMS-626529

A3253-5 ApexBio 5 mg 268.8 EUR
Description: EC50HIV-1 attachment inhibitors represent a new class of entry inhibitors that prevent the initial interaction between virus and host cell by binding to the viral envelope protein gp120 and blocking attachment of the virus to the CD4 receptor on CD4+ T-cells.

BMS-626529

A3253-50 ApexBio 50 mg 1104 EUR
Description: EC50HIV-1 attachment inhibitors represent a new class of entry inhibitors that prevent the initial interaction between virus and host cell by binding to the viral envelope protein gp120 and blocking attachment of the virus to the CD4 receptor on CD4+ T-cells.

BMS-663068

A3254-5 ApexBio 5 mg 360 EUR
Description: BMS-663068 is a small-molecule attachment inhibitor of HIV-1 gp120 with IC50 value of [1].The first step of HIV-1 virus to entry host cells is the binding of the viral gp120 envelope glycopeptide to the CD4 receptor of host cell.

BMS-663068

A3254-5.1 ApexBio 10 mM (in 1mL DMSO) 477.6 EUR
Description: BMS-663068 is a small-molecule attachment inhibitor of HIV-1 gp120 with IC50 value of [1].The first step of HIV-1 virus to entry host cells is the binding of the viral gp120 envelope glycopeptide to the CD4 receptor of host cell.

BMS-690514

A3256-10 ApexBio 10 mg 831.6 EUR
Description: BMS-690514, a potent inhibitor of human epidermal growth factor receptor (HER/EGFR).

BMS-690514

A3256-5 ApexBio 5 mg 540 EUR
Description: BMS-690514, a potent inhibitor of human epidermal growth factor receptor (HER/EGFR).

BMS-690514

A3256-5.1 ApexBio 10 mM (in 1mL DMSO) 480 EUR
Description: BMS-690514, a potent inhibitor of human epidermal growth factor receptor (HER/EGFR).

BMS-690514

A3256-50 ApexBio 50 mg 2043.6 EUR
Description: BMS-690514, a potent inhibitor of human epidermal growth factor receptor (HER/EGFR).

BMS-833923

A3258-10 ApexBio 10 mg 157.2 EUR
Description: BMS-833923 is an orally bioavailable and selective antagonist of smoothened (SMO) with IC50 value of 5.8 nM in NIH3T3 cell line [1].The Hedgehog (Hh) signaling is a critical pathway involved in embryonic development and in tissue maintenance and repair in adults.

BMS-833923

A3258-5 ApexBio 5 mg 122.4 EUR
Description: BMS-833923 is an orally bioavailable and selective antagonist of smoothened (SMO) with IC50 value of 5.8 nM in NIH3T3 cell line [1].The Hedgehog (Hh) signaling is a critical pathway involved in embryonic development and in tissue maintenance and repair in adults.

BMS-833923

A3258-5.1 ApexBio 10 mM (in 1mL DMSO) 200.4 EUR
Description: BMS-833923 is an orally bioavailable and selective antagonist of smoothened (SMO) with IC50 value of 5.8 nM in NIH3T3 cell line [1].The Hedgehog (Hh) signaling is a critical pathway involved in embryonic development and in tissue maintenance and repair in adults.

BMS-833923

A3258-50 ApexBio 50 mg 338.4 EUR
Description: BMS-833923 is an orally bioavailable and selective antagonist of smoothened (SMO) with IC50 value of 5.8 nM in NIH3T3 cell line [1].The Hedgehog (Hh) signaling is a critical pathway involved in embryonic development and in tissue maintenance and repair in adults.

BMS-927711

A3259-10 ApexBio 10 mg 753.6 EUR
Description: BMS-927711 is an orally potent CGRP receptor antagonist with IC50 of 0.14 nM. [1]Calcitonin gene-related peptide CGRP is a 37 amino acid peptide widely distributed in the nervous system, which is a highly potent vasodilator that has been directly implicated in the pathology of migraine.

BMS-927711

A3259-100 ApexBio 100 mg 4620 EUR
Description: BMS-927711 is an orally potent CGRP receptor antagonist with IC50 of 0.14 nM. [1]Calcitonin gene-related peptide CGRP is a 37 amino acid peptide widely distributed in the nervous system, which is a highly potent vasodilator that has been directly implicated in the pathology of migraine.

BMS-927711

A3259-5 ApexBio 5 mg 451.2 EUR
Description: BMS-927711 is an orally potent CGRP receptor antagonist with IC50 of 0.14 nM. [1]Calcitonin gene-related peptide CGRP is a 37 amino acid peptide widely distributed in the nervous system, which is a highly potent vasodilator that has been directly implicated in the pathology of migraine.

BMS-927711

A3259-50 ApexBio 50 mg 2666.4 EUR
Description: BMS-927711 is an orally potent CGRP receptor antagonist with IC50 of 0.14 nM. [1]Calcitonin gene-related peptide CGRP is a 37 amino acid peptide widely distributed in the nervous system, which is a highly potent vasodilator that has been directly implicated in the pathology of migraine.

BMS-707035

A4069-10 ApexBio 10 mg 234 EUR
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-707035

A4069-100 ApexBio 100 mg 1062 EUR
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-707035

A4069-5 ApexBio 5 mg 157.2 EUR
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-707035

A4069-50 ApexBio 50 mg 672 EUR
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-911543

A4152-10 ApexBio 10 mg 480 EUR
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity.

BMS-911543

A4152-25 ApexBio 25 mg 714 EUR
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity.

BMS-911543

A4152-5 ApexBio 5 mg 292.8 EUR
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity.

BMS-911543

A4152-50 ApexBio 50 mg 992.4 EUR
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity.

BMS-536924

A2238-10 ApexBio 10 mg 296.4 EUR
Description: BMS-536924 is a novel inhibitor of IGF-1R with IC50 value of 100nM [1].It has been found that BMS-536924 has cell toxicity in OVCAR-3 and OVCAR-4 cell lines.

BMS-536924

A2238-5 ApexBio 5 mg 199.2 EUR
Description: BMS-536924 is a novel inhibitor of IGF-1R with IC50 value of 100nM [1].It has been found that BMS-536924 has cell toxicity in OVCAR-3 and OVCAR-4 cell lines.

BMS-536924

A2238-5.1 ApexBio 10 mM (in 1mL DMSO) 309.6 EUR
Description: BMS-536924 is a novel inhibitor of IGF-1R with IC50 value of 100nM [1].It has been found that BMS-536924 has cell toxicity in OVCAR-3 and OVCAR-4 cell lines.

BMS-536924

A2238-50 ApexBio 50 mg 1104 EUR
Description: BMS-536924 is a novel inhibitor of IGF-1R with IC50 value of 100nM [1].It has been found that BMS-536924 has cell toxicity in OVCAR-3 and OVCAR-4 cell lines.

BMS-582949

B6187-1 ApexBio 1 mg 174 EUR
Description: IC50: 13 nMBMS-582949 is a p38 MAPK inhibitorp38R MAP kinase plays a key role in regulating the biosynthesis of various inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-1?.

BMS-582949

B6187-25 ApexBio 25 mg 932.4 EUR
Description: IC50: 13 nMBMS-582949 is a p38 MAPK inhibitorp38R MAP kinase plays a key role in regulating the biosynthesis of various inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-1?.

BMS-582949

B6187-5 ApexBio 5 mg 348 EUR
Description: IC50: 13 nMBMS-582949 is a p38 MAPK inhibitorp38R MAP kinase plays a key role in regulating the biosynthesis of various inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-1?.

BMS-986205

B1839-25 Biovision each 966 EUR

BMS-986205

B1839-5 Biovision each 288 EUR

BMS-536924

B1908-1 Biovision each 170.4 EUR

BMS-536924

B1908-5 Biovision each 496.8 EUR

BMS-833923

9547-25 Biovision each 652.8 EUR

BMS-833923

9547-5 Biovision each 210 EUR

BMS-299897

9606-25 Biovision each 810 EUR

BMS-299897

9606-5 Biovision each 248.4 EUR

BMS-777607

A5703-100 ApexBio 100 mg 1005.6 EUR
Description: BMS 777607 is a novel, selective and orally available ATP-competitive MET kinase inhibitor that primarily targets several MET family members, including RON, MET, Tyro-3 and AxI.